Health-related quality of life of carfilzomib- and daratumumab-based therapies in patients with relapsed/refractory multiple myeloma, based on German benefit assessment data

Overview of attention for article published in Quality of Life Research, September 2019

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 2 X users

facebook: 1 Facebook page

Citations

dimensions_citation: 13 Dimensions

Readers on

mendeley: 50 Mendeley

Summary X Facebook Dimensions citations

So far, Altmetric has seen 1 public wall post.

Healtheconbot, 24 Sep 2019

#HealthEconJA Health-related quality of life of carfilzomib- and daratumumab-based therapies in patients with relapsed/refractory…